Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Difan Zheng

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Oncotarget|May 26, 2016
MET exon 14 skipping defines a unique molecular class of non-small cell lung cancerDifan Zheng, Rui Wang, Ting Ye, et al.
Journal of Surgical Oncology|December 12, 2018
The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancerChongze Yuan, Xiaoting Tao, Difan Zheng, et al.
International Journal of Cancer|September 20, 2018
Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patientsYunjian Pan, Chongze Yuan, Chao Cheng, et al.
Chest|May 15, 2018
Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional StudyYang Zhang, Difan Zheng, Juntao Xie, et al.
Scientific Reports|September 11, 2015
EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and PrognosisChao Cheng, Rui Wang, Yuan Li, et al.
Journal of Cancer Research and Clinical Oncology|June 9, 2019
A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapyHan Han, Yue Zhao, Zhendong Gao, et al.
Journal of Cancer Research and Clinical Oncology|February 17, 2017
Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resectionYiyang Wang, Rui Wang, Difan Zheng, et al.
Journal of Cancer Research and Clinical Oncology|June 16, 2017
The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operationYiyang Wang, Rui Wang, Difan Zheng, et al.
Journal of Cancer Research and Clinical Oncology|January 26, 2018
A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid componentJing Li, Wenjie You, Difan Zheng, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2015
Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populationsDifan Zheng, Rui Wang, Yang Zhang, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Oncotarget|May 26, 2016
MET exon 14 skipping defines a unique molecular class of non-small cell lung cancerDifan Zheng, Rui Wang, Ting Ye, et al.
Journal of Surgical Oncology|December 12, 2018
The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancerChongze Yuan, Xiaoting Tao, Difan Zheng, et al.
International Journal of Cancer|September 20, 2018
Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patientsYunjian Pan, Chongze Yuan, Chao Cheng, et al.
Chest|May 15, 2018
Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional StudyYang Zhang, Difan Zheng, Juntao Xie, et al.
Scientific Reports|September 11, 2015
EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and PrognosisChao Cheng, Rui Wang, Yuan Li, et al.
Journal of Cancer Research and Clinical Oncology|June 9, 2019
A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapyHan Han, Yue Zhao, Zhendong Gao, et al.
Journal of Cancer Research and Clinical Oncology|February 17, 2017
Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resectionYiyang Wang, Rui Wang, Difan Zheng, et al.
Journal of Cancer Research and Clinical Oncology|June 16, 2017
The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operationYiyang Wang, Rui Wang, Difan Zheng, et al.
Journal of Cancer Research and Clinical Oncology|January 26, 2018
A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid componentJing Li, Wenjie You, Difan Zheng, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2015
Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populationsDifan Zheng, Rui Wang, Yang Zhang, et al.
Pageof 5